These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18370169)

  • 1. Genetic analysis of Caenorhabditis elegans innate immunity.
    Shapira M; Tan MW
    Methods Mol Biol; 2008; 415():429-42. PubMed ID: 18370169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caenorhabditis elegans as a model for innate immunity to pathogens.
    Gravato-Nobre MJ; Hodgkin J
    Cell Microbiol; 2005 Jun; 7(6):741-51. PubMed ID: 15888078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-glycans are involved in the response of Caenorhabditis elegans to bacterial pathogens.
    Shi H; Tan J; Schachter H
    Methods Enzymol; 2006; 417():359-89. PubMed ID: 17132514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans.
    Wilkins C; Dishongh R; Moore SC; Whitt MA; Chow M; Machaca K
    Nature; 2005 Aug; 436(7053):1044-7. PubMed ID: 16107852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swietenia macrophylla extract promotes the ability of Caenorhabditis elegans to survive Pseudomonas aeruginosa infection.
    Dharmalingam K; Tan BK; Mahmud MZ; Sedek SA; Majid MI; Kuah MK; Sulaiman SF; Ooi KL; Khan NA; Muhammad TS; Tan MW; Shu-Chien AC
    J Ethnopharmacol; 2012 Jan; 139(2):657-63. PubMed ID: 22193176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of bacterial pathogenesis determines phenotype in elt-2 and elt-7 RNAi Caenorhabditis elegans.
    Elliott SL; Sturgeon CR; Travers DM; Montgomery MC
    Dev Comp Immunol; 2011 May; 35(5):521-4. PubMed ID: 21168435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary perspectives on innate immunity from the study of Caenorhabditis elegans.
    Kim DH; Ausubel FM
    Curr Opin Immunol; 2005 Feb; 17(1):4-10. PubMed ID: 15653303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heritable and inducible gene knockdown in C. elegans using Wormgate and the ORFeome.
    Johnson NM; Behm CA; Trowell SC
    Gene; 2005 Oct; 359():26-34. PubMed ID: 15994029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TILLING is an effective reverse genetics technique for Caenorhabditis elegans.
    Gilchrist EJ; O'Neil NJ; Rose AM; Zetka MC; Haughn GW
    BMC Genomics; 2006 Oct; 7():262. PubMed ID: 17049087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi screens in Caenorhabditis elegans in a 96-well liquid format and their application to the systematic identification of genetic interactions.
    Lehner B; Tischler J; Fraser AG
    Nat Protoc; 2006; 1(3):1617-20. PubMed ID: 17406454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caenorhabditis elegans: an emerging genetic model for the study of innate immunity.
    Kurz CL; Ewbank JJ
    Nat Rev Genet; 2003 May; 4(5):380-90. PubMed ID: 12728280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine signals modulate the innate immunity of Caenorhabditis elegans through insulin signaling.
    Kawli T; Tan MW
    Nat Immunol; 2008 Dec; 9(12):1415-24. PubMed ID: 18854822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of RNAi technology and fluorescent protein markers to study membrane traffic in Caenorhabditis elegans.
    Poteryaev D; Spang A
    Methods Mol Biol; 2008; 440():331-47. PubMed ID: 18369957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity.
    Kim DH; Feinbaum R; Alloing G; Emerson FE; Garsin DA; Inoue H; Tanaka-Hino M; Hisamoto N; Matsumoto K; Tan MW; Ausubel FM
    Science; 2002 Jul; 297(5581):623-6. PubMed ID: 12142542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative genome-wide RNAi screen in C. elegans for antifungal innate immunity genes.
    Zugasti O; Thakur N; Belougne J; Squiban B; Kurz CL; Soulé J; Omi S; Tichit L; Pujol N; Ewbank JJ
    BMC Biol; 2016 Apr; 14():35. PubMed ID: 27129311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to infection and possible recognition strategies in the innate immune system of Caenorhabditis elegans.
    Nicholas HR; Hodgkin J
    Mol Immunol; 2004 Jul; 41(5):479-93. PubMed ID: 15183927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-animal high-throughput screens: the C. elegans model.
    O'Rourke EJ; Conery AL; Moy TI
    Methods Mol Biol; 2009; 486():57-75. PubMed ID: 19347616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying gene function in Caenorhabditis elegans using RNA-mediated interference.
    Maine EM
    Brief Funct Genomic Proteomic; 2008 May; 7(3):184-94. PubMed ID: 18443013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The worm has turned--microbial virulence modeled in Caenorhabditis elegans.
    Sifri CD; Begun J; Ausubel FM
    Trends Microbiol; 2005 Mar; 13(3):119-27. PubMed ID: 15737730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference in Caenorhabditis elegans.
    Wang J; Barr MM
    Methods Enzymol; 2005; 392():36-55. PubMed ID: 15644174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.